IGFBP7 and acute kidney injury: To that end, Meersch, Zarbock et al. performed the PrevAKI trial, a single-center randomized controlled trial which identified cardiac surgical patients at high risk of AKI by using urinary TIMP-2 and IGFBP7 (Nephrocheck®) four hours after CPB (Table 5).